Regional citrate anticoagulation in critically Ill patients treated with plasma filtration and adsorption

Blood Purification

Volumn 22, Issue 3, 2004, Pages 313-319

  Mariano, Filippo ^a   Tetta, Ciro ^b   Stella, Maurizio ^a   Biolino, Piera ^a   Miletto, Antonio ^a   Triolo, Giorgio ^a  

^a CTO HOSPITAL   (Italy)

^b Cyberonics Inc   (Italy)

Author keywords

Acute renal failure; Plasmafi ltration; Regional citrate anticoagulation; Septic shock; Sorbent technology

Indexed keywords

BICARBONATE; CALCIUM; CITRIC ACID; HEPARIN;

ACUTE KIDNEY FAILURE; ADSORPTION; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD FILTRATION; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COUPLED PLASMA FILTRATION ADSORPTION; CRITICAL ILLNESS; FEASIBILITY STUDY; FEMALE; HUMAN; INSTRUMENTATION; INTERMETHOD COMPARISON; MALE; PH MEASUREMENT; PRIORITY JOURNAL; SAFETY; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTICOAGULANTS; BURNS; CALCIUM; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CITRIC ACID; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; FEMALE; HEMOFILTRATION; HEMORRHAGE; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE TRAUMA; SHOCK, SEPTIC; SORPTION DETOXIFICATION; TREATMENT OUTCOME;

EID: 4444333892     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078788     Document Type: Article

References (20)

1. Baldwin I: Continuous renal replacement therapy. Keeping pace with changes in technology and technique. Blood Purif 2002; 20:269-274.
2. Van de Wetering J, Westendorp RGJ, Hoeven JG, et al: Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-150.
3. Morita Y, Johnson RW, Dorn RE, Hall DS: Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 1961; 242: 32-42.
4. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981.
5. Apsner R, Druml W: More on anticoagulation for continuous hemofiltration. N Engl J Med 1998; 338: 131-132.
6. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with high risk of bleeding. Kidney Int 1999; 55: 1991-1997.
7. Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35: 802-811.
8. Tolwani AJ, Campbell RC, Schenk MB, et al: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-374.
9. Hoffmann JN, Hartl WH, Deppisch R, et al: Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48: 1563-1570.
10. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM: Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 1999; 72:S84-S87.
11. De Vriese AS, Colardyn FA, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-853.
12. Mariano F, Tetta C, Guida CE, et al: Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 2001; 60: 1598-1605.
13. Tetta C, Gianotti L, Cavaillon JM, et al: Continuous plasmafiltration coupled with sorbent adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000; 28: 1526-1533.
14. Ronco C, Brendolan A, Lonnemann G, et al: A pilot study of coupled plasmafiltration with adsorption in septic shock. Crit Care Med 2002; 30: 1250-1255.
15. The ACCP/SCCM Consensus Conference Committee: Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655.
16. Kellum JA, Levin N, Bouman C, Lameire N: Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002; 8: 509-514.
17. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261.
18. Ahmad S, Yeo K, Jensen WM, Landicho D, Gregory B, Moritz J, Kenny M: Citrate anticoagulation during in vivo simulation of slow hemofiltration. Blood Purif 1990; 8: 177-182.
19. Bunker JP, Bendixen HH, Murphy AJ: Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med 1962; 266: 372-377.
20. Bosch T, Heinemann O, Durh C, et al: Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: A prospective controlled clinical trial. Artif Organs 2000; 24: 790-796.